WEDNESDAY, Aug. 9, 2017 -- A small clinical trial showed an immune system therapy was safe for people with type 1 diabetes, British researchers report.
The immunotherapy also showed signs of helping to keep insulin production steady in people newly diagnosed with the disease, the study authors said. However, because this was a placebo-controlled safety trial, there weren't enough people included to know for sure how well the treatment works.
THURSDAY, July 27, 2017 -- That glass of wine or pint of beer you enjoy with dinner every night might come with an added benefit -- a lower risk of type 2 diabetes, a new Danish study contends.
The researchers found that men who had 14 drinks each week and women who had nine drinks a week appeared to have the lowest risk of type 2 diabetes, compared to nondrinkers or people who drank more heavily, said senior researcher Janne Tolstrup.
FRIDAY, July 14, 2017 -- A treatment targeting wayward immune cells in people with type 1 or type 2 diabetes may help even years later, a new study finds.
For the treatment, researchers take blood from a person with diabetes and separate out the immune system cells (lymphocytes). They briefly expose those cells to stem cells from umbilical cord blood from an unrelated infant. Then they return the lymphocytes to the patient's body.